This Article Full Text Full Text (PDF) All Versions of this Article: 39/3/1012    most recent STROKEAHA.107.495069v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Müller, H. D. Articles by Sommer, C. Search for Related Content PubMed PubMed Citation Articles by Müller, H. D. Articles by Sommer, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB MUSCIMOL Medline Plus Health Information Stroke Related Collections Animal models of human disease Other imaging Neuroprotectors Other Stroke Treatment - Medical

(Stroke. 2008;39:1012.)
© 2008 American Heart Association, Inc.

Original Contributions

Brain-Derived Neurotrophic Factor But Not Forced Arm Use Improves Long-Term Outcome After Photothrombotic Stroke and Transiently Upregulates Binding Densities of Excitatory Glutamate Receptors in the Rat Brain

Harald D. Müller, MD; Kiran M. Hanumanthiah, MD; Kai Diederich, MSc; Stefan Schwab, MD; Wolf-Rüdiger Schäbitz, MD Clemens Sommer, MD

From the Department of Neuropathology (H.D.M., C.S.), Johannes Gutenberg-University of Mainz, Mainz, Germany; the Department of Neurology (K.M.H., S.S., W.-R.S.), Ruprecht Karls-University of Heidelberg, Heidelberg, Germany; the Department of Neurology (K.D., W.-R.S.), University of Münster, Münster, Germany; and the Department of Neurology (S.S.), University of Erlangen-Nürmberg, Erlangen, Germany.

Correspondence to Clemens Sommer, MD, Department of Neuropathology, Mainz University Medical Center, Langenbeckstrasse 1, D-55131 Mainz, Germany. E-mail sommer{at}neuropatho.klinik.uni-mainz.de

Background and Purpose— Both application of neurotrophic factors like brain-derived neurotrophic factor (BDNF) and constraint-induced movement therapy like forced arm use have been shown to potentially improve outcome after stroke. The aim of the present study was to check whether postischemic long-term outcome correlates to specific modifications in the abundance of various neurotransmitter receptors.

Methods— Adult male Wistar rats were subjected to photothrombotic ischemia and assigned to various treatment groups (n=5 each) with end points at 3 and 6 weeks: (1) ischemic control (saline); (2) BDNF (ischemia, 20 µg BDNF); (3) forced arm use (ischemia, saline, and ipsilateral plaster cast for 5 or 14 days for the 3- and 6-week groups, respectively); and (4) combined treatment (combi; ischemia, 20 µg BDNF, forced arm use). Animals received intravenous bolus infusions of saline or BDNF 1 hour 3 and 5 days after ischemia, respectively. A group of sham rats (n=2) served as a control. A battery of behavioral tests was performed before and up to 6 weeks after ischemia. Quantitative in vitro receptor autoradiography was performed on 12-µm-thick cryostat sections using [³H]MK-801, [³H]AMPA, and [³H]muscimol for labeling of NMDA, AMPA, and GABA_A receptors, respectively.

Results— Best functional outcome was seen after BDNF treatment, whereas vice versa rats with forced arm use did worse in behavioral performance. Improved behavioral outcome was associated with increased perilesional binding densities of NMDA and AMPA receptors 3 weeks after stroke.

Conclusions— Our findings suggest that transient enhanced neurotransmission as reflected by increased ligand binding of NMDA and AMPA receptors may participate in successful postlesional reorganization processes.

Key Words: forced arm use • receptors • stroke • trophic factors